Welcome to the Annual Accounts section of Neuroendocrine Cancer UK. Here, we provide transparent and detailed insights into our financial activities and stewardship. Our annual accounts offer an overview of how we manage and allocate our resources to support our mission. By sharing this information, we aim to demonstrate our commitment to accountability and the effective use of funds in advancing neuroendocrine cancer research, patient support, and advocacy.
Thank you for your ongoing support and interest in our work.
Neuroendocrine Cancer UK – Registered Charity Number: 1092386
Accounts 2023
Annual report and unaudited financial statements for the year ended 30 September 2023.
Accounts 2022
Annual report and unaudited financial statements for the year ended 30 September 2022.
Accounts 2021
Annual report and unaudited financial statements for the year ended 30 September 2021.
Accounts 2020
Annual report and unaudited financial statements for the year ended 30 September 2020.
Accounts 2019
Annual report and unaudited financial statements for the year ended 30 September 2019.
Accounts 2018
Annual report and unaudited financial statements for the year ended 30 September 2018.
Neuroendocrine Cancer UK’s Strategy 2025-2030
‘No more blind spots: It is time to see neuroendocrine cancer clearly’
Please consider donating to support our vital work in neuroendocrine cancer research, patient care, and advocacy.
Symptoms
Tests
Newly diagnosed
Treatments
What is Neuroendocrine Cancer?
Living with Neuroendocrine Cancer
How we can support you
NC research and our campaign work
End of life care